Market Overview:
The global oral contrast agent market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of gastrointestinal disorders, cancer, and cardiovascular disorders across the globe. In addition, technological advancements in oral contrast agents are also contributing to the growth of this market. Based on type, barium-based contrast media held a dominant position in 2017 and is expected to maintain its dominance during the forecast period as well. This can be attributed to their high usage rates for diagnosing gastrointestinal disorders and other related conditions. However, iodinated contrast media are projected to grow at a higher CAGR during the forecast period owing their growing usage rates for diagnosing cancer and other medical conditions. Based on application, cardiovascular disorders held a leading share in 2017.
Product Definition:
An oral contrast agent is a substance that is swallowed to help improve the visibility of certain organs or tissues during medical imaging procedures. Oral contrast agents are used to improve the visibility of the gastrointestinal tract during procedures such as an x-ray, CT scan, or MRI.
Barium-based Contrast Media:
Barium-based contrast media is used as a radiopaque agent in the field of dentistry for imaging purposes. It is also known as oral barium or tasteless barium and can be administered to patients without any adverse effects. The global Barium-based Contrast Media market size was valued at USD 469.1 million in 2016 and is expected to grow at a CAGR of XX% over the forecast period, which extends till 2022.
Iodinated Contrast Media:
Iodinated contrast media and it's usage in Oral Contrast Agent market is used for enhancing the visibility of specific areas of the body during an MRI scan. It is also used as a diagnostic tool to highlight any damage or abnormalities in tissues, bones, and organs. The product helps radiologists to evaluate soft tissue structures that are often difficult to image using non-contrast imaging techniques.
Global Iodinated Contrast Media.
Application Insights:
Cardiovascular disorders segment dominated the global market in 2017. This is owing to the rising prevalence of cardiovascular diseases, which are a major cause of death globally. According to WHO, around 17 million people died from Cardiovascular Diseases (CVDs) in 2015 globally. In addition, as per the National Center for Biotechnology Information (NCBI), around 31% of deaths occur due to CVDs in India and this number is expected to increase by 2030 with current trends intact. Thus, increasing incidences of heart-related disorders coupled with high mortality rates drive demand for contrast agents used during cardiac surgeries across the globe.
The cancer segment is anticipated to witness lucrative growth over the forecast period owing to increasing incidence rates and awareness programs launched by various governments across countries such as China, India.
Regional Analysis:
Europe dominated the global market in 2017 owing to well-established healthcare infrastructure, high patient awareness levels coupled with relatively higher healthcare expenditure in the region. In addition, growing R&D activities and presence of key manufacturers are anticipated to drive growth during the forecast period. Asia Pacific is expected to witness lucrative growth over the forecast period due to rising geriatric population base and improving economic conditions in emerging countries such as India & China.
Source: Global Iodinated Contrast Media Market Size, Share & Trends Analysis Report By Product Type (Ion-emitting Radiographic Systems/Equipment; Iodinated Contrast Media), By Region (North America; Europe; Asia Pacific.
Growth Factors:
- Increasing incidence of gastrointestinal diseases: The incidence of gastrointestinal diseases is increasing globally, which is expected to drive the demand for oral contrast agents.
- Growing demand for minimally invasive procedures: There is a growing demand for minimally invasive procedures, which is expected to boost the use of oral contrast agents.
- Technological advancements in imaging modalities: There has been a significant advancement in imaging modalities over the past few years, which is likely to increase the adoption of oral contrast agents.
- Rising geriatric population: The global geriatric population is rising rapidly, and this trend is expected to fuel the growth of the oral contrast agent market in coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Oral Contrast Agent Market Research Report
By Type
Barium-based Contrast Media, Iodinated Contrast Media, Gadolinium-based Contrast Media, Microbubble Contrast Media
By Application
Cardiovascular Disorders, Cancer, Gastrointestinal Disorders, Musculoskeletal Disorders, Neurological Disorders, Nephrological Disorders
By Companies
GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany), Guerbet (France), Lantheus (US), Daiichi Sankyo (Japan), Unijules Life Sciences (India), J.B. Chemicals and Pharmaceuticals (India), Spago Nanomedicine (Sweden), Taejoon Pharm (South Korea), GE Healthcare (US), Magnus Health (India)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Oral Contrast Agent Market Report Segments:
The global Oral Contrast Agent market is segmented on the basis of:
Types
Barium-based Contrast Media, Iodinated Contrast Media, Gadolinium-based Contrast Media, Microbubble Contrast Media
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cardiovascular Disorders, Cancer, Gastrointestinal Disorders, Musculoskeletal Disorders, Neurological Disorders, Nephrological Disorders
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GE Healthcare (US)
- Bracco Imaging (Italy)
- Bayer HealthCare (Germany)
- Guerbet (France)
- Lantheus (US)
- Daiichi Sankyo (Japan)
- Unijules Life Sciences (India)
- J.B. Chemicals and Pharmaceuticals (India)
- Spago Nanomedicine (Sweden)
- Taejoon Pharm (South Korea)
- GE Healthcare (US)
- Magnus Health (India)
Highlights of The Oral Contrast Agent Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Barium-based Contrast Media
- Iodinated Contrast Media
- Gadolinium-based Contrast Media
- Microbubble Contrast Media
- By Application:
- Cardiovascular Disorders
- Cancer
- Gastrointestinal Disorders
- Musculoskeletal Disorders
- Neurological Disorders
- Nephrological Disorders
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oral Contrast Agent Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Oral contrast agents are medications that help doctors see better during medical procedures by providing a contrasting image on x-rays.
Some of the major players in the oral contrast agent market are GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany), Guerbet (France), Lantheus (US), Daiichi Sankyo (Japan), Unijules Life Sciences (India), J.B. Chemicals and Pharmaceuticals (India), Spago Nanomedicine (Sweden), Taejoon Pharm (South Korea), GE Healthcare (US), Magnus Health (India).
The oral contrast agent market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Oral Contrast Agent Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Oral Contrast Agent Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Oral Contrast Agent Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Oral Contrast Agent Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Oral Contrast Agent Market Size & Forecast, 2020-2028
4.5.1 Oral Contrast Agent Market Size and Y-o-Y Growth
4.5.2 Oral Contrast Agent Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Barium-based Contrast Media
5.2.2 Iodinated Contrast Media
5.2.3 Gadolinium-based Contrast Media
5.2.4 Microbubble Contrast Media
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Cardiovascular Disorders
6.2.2 Cancer
6.2.3 Gastrointestinal Disorders
6.2.4 Musculoskeletal Disorders
6.2.5 Neurological Disorders
6.2.6 Nephrological Disorders
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Oral Contrast Agent Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Oral Contrast Agent Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Barium-based Contrast Media
9.6.2 Iodinated Contrast Media
9.6.3 Gadolinium-based Contrast Media
9.6.4 Microbubble Contrast Media
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Cardiovascular Disorders
9.10.2 Cancer
9.10.3 Gastrointestinal Disorders
9.10.4 Musculoskeletal Disorders
9.10.5 Neurological Disorders
9.10.6 Nephrological Disorders
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Barium-based Contrast Media
10.6.2 Iodinated Contrast Media
10.6.3 Gadolinium-based Contrast Media
10.6.4 Microbubble Contrast Media
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Cardiovascular Disorders
10.10.2 Cancer
10.10.3 Gastrointestinal Disorders
10.10.4 Musculoskeletal Disorders
10.10.5 Neurological Disorders
10.10.6 Nephrological Disorders
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Barium-based Contrast Media
11.6.2 Iodinated Contrast Media
11.6.3 Gadolinium-based Contrast Media
11.6.4 Microbubble Contrast Media
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Cardiovascular Disorders
11.10.2 Cancer
11.10.3 Gastrointestinal Disorders
11.10.4 Musculoskeletal Disorders
11.10.5 Neurological Disorders
11.10.6 Nephrological Disorders
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Barium-based Contrast Media
12.6.2 Iodinated Contrast Media
12.6.3 Gadolinium-based Contrast Media
12.6.4 Microbubble Contrast Media
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Cardiovascular Disorders
12.10.2 Cancer
12.10.3 Gastrointestinal Disorders
12.10.4 Musculoskeletal Disorders
12.10.5 Neurological Disorders
12.10.6 Nephrological Disorders
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Barium-based Contrast Media
13.6.2 Iodinated Contrast Media
13.6.3 Gadolinium-based Contrast Media
13.6.4 Microbubble Contrast Media
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Cardiovascular Disorders
13.10.2 Cancer
13.10.3 Gastrointestinal Disorders
13.10.4 Musculoskeletal Disorders
13.10.5 Neurological Disorders
13.10.6 Nephrological Disorders
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Oral Contrast Agent Market: Competitive Dashboard
14.2 Global Oral Contrast Agent Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GE Healthcare (US)
14.3.2 Bracco Imaging (Italy)
14.3.3 Bayer HealthCare (Germany)
14.3.4 Guerbet (France)
14.3.5 Lantheus (US)
14.3.6 Daiichi Sankyo (Japan)
14.3.7 Unijules Life Sciences (India)
14.3.8 J.B. Chemicals and Pharmaceuticals (India)
14.3.9 Spago Nanomedicine (Sweden)
14.3.10 Taejoon Pharm (South Korea)
14.3.11 GE Healthcare (US)
14.3.12 Magnus Health (India)
